Please assess the completion status of the following clinical trial:

Trial Title: Arthroscopic Rotator Cuff Repair Augmented With Platelet Rich Plasma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults between 50 and 75 years with a defined complete rotator cuff tear as compatible clinical and confirmation by magnetic resonance imaging (MRI).~* Minimum of 3 months of failed conservative treatment (anti-inflammatory, physical therapy and infiltration with corticosteroids)~Exclusion Criteria:~* Refusal to participate or informed consent,~* Revision surgery,~* Partial repair,~* Patients with shoulder osteoarthritis\> 2~* Advanced fat infiltration of the rotator cuff muscles (STAGE 3 or 4)~* Systemic or rheumatoid arthritis,~* Uncontrolled diabetes, (patients for whom surgery is contraindicated in the preoperative evaluation by the clinician and anesthesiologist)~* Acute or chronic infections of the shoulder to be operated on~* Ongoing cancer chemotherapy therapies~* Sepsis, septic arthritis, osteomyelitis or other ongoing infectious processes;~* Previous operations on the affected shoulder,~* Patients with autoimmune diseases;~* Pregnant

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Arthroscopic rotator cuff repair and platelet rich plasma (Type: EXPERIMENTAL): A standard double-row arthroscopic rotator cuff repair will be performed and at the end of the procedure 10 ml of autologous platelet-rich plasma will be placed under direct vision at the tendon-bone interface.
- Arthroscopic rotator cuff repair (Type: ACTIVE_COMPARATOR): A standard double-row arthroscopic rotator cuff repair will be performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).